|
GlaxoSmithKline Plc.
International Transfer Pricing and Taxation
Mahendra R Gujarathi,
Bentley College
ABSTRACT. This comprehensive case intends to further your understanding of the complexities involved in the international transfer pricing and taxation of intangibles. The backdrop for the case is GlaxoSmithKline’s $3.4 billion settlement in 2006 with the Internal Revenue Service. Given the subjectivity in the implementation of transfer pricing methods, you are required to provide possible rationales for the positions taken by GSK as well as the IRS. You are also required to present calculations under different methods, identify the most appropriate method, compute Foreign Tax Credits for different scenarios, and suggest possible strategies for multinational corporations to reduce the odds of negative settlements with tax authorities.
Full-Text is no longer available online. Please contact the author(s) for more information about this manuscript.
Back to Session Listing
|